銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Divi's Laboratories
DIVISLAB ?NSE

Divi's Laboratories

?6,750.00-17.00 (0.25%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
6,736.50
Today’s high
6,795.00
52 week low
5,636.50
52 week high
7,071.50
Open price
6,790.00
Previous close
6,767.00
Live volume
1,63,809
Lower circuit
6,090.50
Upper circuit
7,443.50

Fundamentals

Market Cap
?1,79,647Cr
ROE
15.32%
P/E Ratio(TTM)
69.96
EPS(TTM)
96.73
P/B Ratio
10.72
Dividend Yield
0.44%
Industry P/E
33.86
Book Value
631.38
Debt to Equity
0.00
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?2,986
+10.92%
Profit (Cr)
?751
+28.82%
08751.75k2.63k3.5k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+12%
3Y CAGR+2%
Profit growthValue
1Y (TTM)+13%
3Y CAGR-10%

About

Divi's Laboratories is a prominent global manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Custom Synthesis for innovator companies, and high-quality Nutraceutical ingredients. The company's vision is to create lasting value for its stakeholders by producing superior generic APIs and custom intermediates for the global pharmaceutical and nutraceutical industries. It aims to be a responsible business, adding value through its expertise in chemistry and serving the community with diverse social initiatives for a better future. As an API-exclusive manufacturer, Divi's focuses solely on producing ingredients and does not compete with its customers by marketing the final medicine formulations. A key operational strength is its backward-integrated model, which allows the company to produce most key starting materials internally, ensuring quality and supply security. This business model has made Divi's a trusted global supplier to pharmaceutical companies across more than 100 countries, with exports making up 88% of its revenue.;
CEO/MD
Dr. Kiran S. Divi
Founded in
1990
NSE symbol
DIVISLAB

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
51.88%
Foreign Institutions
20.29%
Mutual Funds
13.42%
Retail And Others
8.61%
Other Domestic Institutions
5.80%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?2,198.60
-3.60 (0.16%)
L
    H
    36,306.8035.343.51
    ?1,224.70
    +17.90 (1.48%)
    L
      H
      25,592.8073.3510.3
      ?17,332.00
      +112.00 (0.65%)
      L
        H
        22,082.7460.6711.79
        ?159.79
        -0.41 (0.26%)
        L
          H
          21,328.20--2.61
          Livesquawk ?
          Divi's Laboratories saw an NSE block trade worth Rs. 67.2 crore. The trade involved 102,210 shares at Rs. 6,575.50 per share.
          Livesquawk ?
          Kotak maintains 'Sell' on Divi's Labs with ?5850 target, citing Q4 miss from softer CSM growth. Concerns include high capex intensity, expensive valuations, despite strong client engagement and peptide projects.
          Livesquawk ?
          Jefferies maintains Buy on Divi's Labs with a ?7,950 target, citing Custom Synthesis, nutraceutical growth. Weak generics sales and regulatory uncertainty on key CS projects are flagged despite strong growth guidance.
          Livesquawk ?
          Divi's Labs forecasts double-digit revenue growth despite industry uncertainty. The company predicts stable margins, maintaining resilience in challenging conditions.
          Livesquawk ?
          Divi's Lab Q4 net profit rises to ?7.5B vs ?6.6B YoY. Q4 revenue grows to ?28.3B from ?25.85B YoY.
          Livesquawk ?
          Divi's Laboratories saw an NSE block trade of 26,241 shares. The trade was valued at Rs. 18.1 crore, executed at Rs. 6,906.5/share.
          2026

          24
          Jul
          Dividend
          Upcoming
          Ex date
          ?30.00
          per share

          For each share you hold, you will receive ?30.00
          Dividend amount?30.00 per share
          Dividend TypeFinal
          Ex Date24 Jul ‘26
          Record Date24 Jul ‘26
          Announcement date23 May ‘26

          23
          May
          Dividend
          Announced
          ?30.00
          per share

          For each share you hold, you will receive ?30.00
          Dividend amount?30.00 per share
          Dividend TypeFinal
          Ex Date24 Jul ‘26
          Record Date24 Jul ‘26
          Announcement date23 May ‘26
          23
          May
          Quarterly & Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          7
          Nov
          Quarterly Result
          Release date
          6
          Aug
          Quarterly Result
          Release date

          25
          Jul
          Dividend
          Ex date
          ?30.00
          per share

          For each share you hold, you will receive ?30.00
          Dividend amount?30.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date17 May ‘25

          17
          May
          Dividend
          Announced
          ?30.00
          per share

          For each share you hold, you will receive ?30.00
          Dividend amount?30.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date17 May ‘25
          2024

          2
          Aug
          Dividend
          Ex date
          ?30.00
          per share

          For each share you hold, you will receive ?30.00
          Dividend amount?30.00 per share
          Dividend TypeFinal
          Ex Date2 Aug ‘24
          Record Date2 Aug ‘24
          Announcement date25 May ‘24
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com